Acute Respiratory Distress Syndrome and Corticosteroids: Reconciling Conflicting Evidence
Keywords:
Respiratory distress syndrome, glucocorticoids, dexamethasone, respiration, artificial, prone position, precision medicineAbstract
Acute respiratory distress syndrome (ARDS) is a life-threatening form of acute inflammatory lung injury in which loss of alveolar-capillary membrane integrity produces protein-rich pulmonary edema, refractory hypoxemia, and reduced lung compliance, typically within 6–72 hours of a precipitating insult. The 2012 Berlin criteria defined ARDS by acute onset within one week of a known insult, bilateral opacities not fully explained by effusion, atelectasis, or cardiac failure, and a PaO₂/FiO₂ ratio of 300 mmHg or less with a minimum PEEP of 5 cmH₂O. The 2023 global definition expands this framework by accepting SpO₂/FiO₂ of 315 or less when SpO₂ is 97% or below, including patients supported with high-flow nasal oxygen at 30 L/min or more, permitting thoracic ultrasonography as an alternative imaging modality, and waiving the PEEP requirement in resource-limited settings. These revisions are particularly relevant to practice in low- and middle-income countries, where arterial blood gas analysis and mechanical ventilation may be unavailable. Management remains anchored in lung-protective ventilation, conservative fluid strategy, and prone positioning. Glucocorticoids remain the most contested pharmacological intervention: evidence from dexamethasone trials in ARDS and in COVID-19 suggests benefit in selected populations, yet questions persist regarding optimal agent, dose, timing relative to symptom onset, duration, the influence of ARDS subphenotypes, and the risk of secondary infection and neuromuscular weakness. This narrative review summarizes the pathophysiology, evolving diagnostic criteria, imaging findings, and current evidence on corticosteroid therapy, and considers how hyperinflammatory and hypoinflammatory subphenotypes may guide future trial design and individualized treatment.References
Ashbaugh DG. Acute respiratory distress in adults. Lancet. 1967;2(7511):319-23.
Loscalzo JFA, Kasper D, Hauser S, Longo D, Jameson J. Harrison's principles of internal medicine. 21st edtion. Vol. 1. New York: McGraw-Hill Global Education Holdings, LLC; 2022. p. 4132.
Meduri GU. Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation. 2005; 12(6):321-38.
Meduri GU, Yates CR. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS. Ann N Y Acad Sci. 2004;1024:24-53.
Parsons PE. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33(1):1-6, 230-2.
Gajic O. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med. 2011;183(4):462-70.
Wang Y. The association between etiologies and mortality in acute respiratory distress syndrome: Amulticenter observational cohort study. Front Med (Lausanne). 2021;8:739596.
Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008;133(5):1120-7.
Shrestha GS. COVID-19: Current understanding of pathophysiology. J Nepal Health Res Counc. 2020; 18(3):351-359.
Sedhai YR. Validating measures of disease severity in acute respiratory distress syndrome. Ann Am Thorac Soc. 2021;18(7):1211-8.
Sharma NS. The neutrophil chemoattractant peptide proline-glycine-proline is associated with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2018;315(5):L653-l661.
Ranieri VM. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-33.
Rubenfeld GD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685-93.
Trillo-Alvarez C. Acute lung injury prediction score: derivation and validation in a population-based sample. Eur Respir J. 2011;37(3):604-9.
Mikkelsen ME. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock. 2013;40(5):375-81.
Kor DJ. Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open. 2012;2(5).
Gattinoni L. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med. 1998;158(1):3-11.
Lim CM. Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment strategy, etiological category of diffuse lung injury, and body position of the patient. Crit Care Med. 2003;31(2):411-8.
Tugrul S. Effects of sustained inflation and postinflation positive end-expiratory pressure in acute respiratory distress syndrome: focusing on pulmonary and extrapulmonary forms. Crit Care Med. 2003;31(3): 738-44.
Pelosi P. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 2003;42:48s-56s.
Zaccardelli DS, Pattishall EN. Clinical diagnostic criteria of the adult respiratory distress syndrome in the intensive care unit. Crit Care Med. 1996;24(2):247-51.
Pepe PE. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144(1):124-30.
Villar J. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011; 37(12):1932-41.
Zilberberg M.D, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med. 1998; 157(4 Pt 1):1159-64.
Hudson LD. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151(2 Pt 1):293-301.
Doyle RL. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1818-24.
Fein AM. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest. 1983;83(1):40-2.
Moss M, Burnham EL. Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction. Crit Care Med. 2003;31(4 Suppl):207-12.
Moss M. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med. 2003; 31(3):869-77.
Dohrman DP, Diamond I, Gordon AS. The role of the neuromodulator adenosine in alcohol's actions. Alcohol Health Res World. 1997;21(2):136-43.
Nagy LE. Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol. 1989; 36(5):744-8.
Dada L. Alcohol worsens acute lung injury by inhibiting alveolar sodium transport through the adenosine A1 receptor. PLoS One. 2012;7(1):e30448.
Factor P. Adenosine regulation of alveolar fluid clearance. Proc Natl Acad Sci USA. 2007;104(10):4083-8.
Afshar M. Blood alcohol content, injury severity, and adult respiratory distress syndrome. J Trauma Acute Care Surg. 2014;76(6):1447-55.
Calfee CS. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med. 2011;183(12):1660-5.
Iribarren C. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest. 2000;117(1):163-8.
Buzby GP. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139(1): 160-7.
Dempsey DT, Mullen JL. Prognostic value of nutritional indices. JPEN J Parenter Enteral Nutr. 1987; 11(5 Suppl):109s-114s.
Mangialardi RJ. Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med. 2000;28(9): 3137-45.
Aman J. Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011;39(1):89-97.
Karnatovskaia LV. Obstructive sleep apnea, obesity, and the development of acute respiratory distress syndrome. J Clin Sleep Med. 2014;10(6):657-62.
Albert RK. The role of ventilation-induced surfactant dysfunction and atelectasis in causing acute respiratory distress syndrome. Am J Respir Crit Care Med. 2012; 185(7):702-8.
Wang C. Obesity, inflammation, and lung injury (OILI): the good. Mediators Inflamm. 2014;2014: 978463.
Leal Vde O, Mafra D. Adipokines in obesity. Clin Chim Acta. 2013;419:87-94.
Mancuso P. Obesity and lung inflammation. J Appl Physiol (1985). 2010;108(3):722-8.
Simpson SQ, Casey LC. Role of tumor necrosis factor in sepsis and acute lung injury. Crit Care Clin. 1989; 5(1):27-47.
Moss M. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med. 2000;28(7):2187-92.
Gu WJ. Risk of acute lung injury/acute respiratory distress syndrome in critically ill adult patients with pre-existing diabetes: A meta-analysis. PLoS One. 2014;9(2):e90426.
Filgueiras LR. Jr. Sepsis-induced acute lung injury (ALI) is milder in diabetic rats and correlates with impaired NFkB activation. PLoS One. 2012;7(9): e44987.
Siegel MD. Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults. 2024.
Rubenfeld GD. Interobserver variability in applying a radiographic definition for ARDS. Chest. 1999;116(5): 1347-53.
Goodman LR. Congestive heart failure and adult respiratory distress syndrome. New insights using computed tomography. Radiol Clin North Am. 1996; 34(1):33-46.
Gattinoni L. Adult respiratory distress syndrome profiles by computed tomography. J Thorac Imaging, 1986;1(3):25-30.
Pelosi P. Computed tomography in adult respiratory distress syndrome: what has it taught us? Eur Respir J. 1996;9(5):1055-62.
Chiumello D. Global and regional diagnostic accuracy of lung ultrasound compared to CT in patients with acute respiratory distress syndrome. Crit Care Med. 2019;47(11):1599-606.
Plantinga C. Use of lung ultrasound in the new definitions of acute respiratory distress syndrome increases the occurrence rate of acute respiratory distress syndrome. Crit Care Med. 2024;52(2): e100-e104.
Smit MR. Lung ultrasound prediction model for acute respiratory distress syndrome: a multicenter prospective observational study. Am J Respir Crit Care Med. 2023;207(12):1591-601.
George R. Chesson A, Rennard S. Functional anatomy of the respiratory system. Chest medicine essentials of pulmonary and critical care medicine. 3rd edition. Baltimore: Lippincott Williams & Wilkins; 1995.
Matthay MA. Acute hypoxemic respiratory failure: Pulmonary edema and ARDS. Chest medicine. Essentials of pulmonary and critical care medicine. 3rd ed. In: George RB, Light RW, Matthay MA, et al (Eds). Baltimore: Williams & Wilkins; 1995. p. 593.
Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Annals of Internal Medicine. 2004. 141(6):460-70.
Martin TR. Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest. 1999;116(1 Suppl):2s-8s.
Colletti LM. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990;85(6): 1936-43.
Donnelly SC. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med. 1996;125(3):191-6.
Miller EJ, Cohen AB, Matthay MA. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med. 1996;24(9): 1448-54.
Windsor A. Role of the neutrophil in adult respiratory distress syndrome. British Journal of Surgery. 1993; 80(1):10-7.
Roumen R. Serum lipofuscin as a prognostic indicator of adult respiratory distress syndrome and multiple organ failure. British Journal of Surgery. 1994;81(9): 1300-5.
Fein A. The value of edema fluid protein measurement in patients with pulmonary edema. The American Journal of Medicine. 1979;67(1):32-8.
Calandrino Jr, FS. Pulmonary vascular permeability during the adult respiratory distress syndrome: a positron emission tomographic study. Am Rev Respir Dis. 1988;138(2):421-8.
Ware LB, Matthay MA. The acute respiratory distress syndrome. New England Journal of Medicine. 2000; 342(18):1334-49.
Meduri GU. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med. 2002;165(7):983-91.
Meduri GU. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998; 280(2):159-65.
Meduri GU. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954-63.
Steinberg KP. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671-84.
Meduri GU. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42(5):829-40.
Meduri GU. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1432-41.
Chaudhuri D. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Medicine. 2021;47(5): 521-37.
Lin P. Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis. Crit Care. 2021;25(1): 122.
Chang X. Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data. Respir Res. 2022;23(1):301.
Baek MS. Effect of corticosteroid therapy in the early phase of acute respiratory distress syndrome: a propensity-matched cohort study. Korean J Intern Med. 2021;36(1):145-53.
Tongyoo S. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016; 20(1):329.
Villar J. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267-76.
Horby P. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693-704.
Yoshihiro S. Steroid treatment in patients with acute respiratory distress syndrome: a systematic review and network meta-analysis. J Anesth. 2022;36(1):107-21.
Cronin L. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995;23(8):1430-9.
Lieberman P, Patterson R, Kunske R. Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol. 1972;49(6):329-36.
Zuckerman S, Palmer A, Hanson DA. The effect of steroid hormones on the water content of tissues. J Endocrinol. 1950;6(3):261-76.
Wiedemann HP. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354(24):2564-75.
Bihari S. Sodium balance, not fluid balance, is associated with respiratory dysfunction in mechanically ventilated patients: a prospective, multicentre study. Crit Care Resusc. 2015;17(1):23-8.
Neamu RF, Martin GS. Fluid management in acute respiratory distress syndrome. Curr Opin Crit Care. 2013;19(1):24-30.
Li G. Efficacy of corticosteroids in patients with acute respiratory distress syndrome: a meta-analysis. Annals of Medicine. 2024;56(1):2381086.
Bourenne J, Carvelli J, Papazian L. Evolving definition of acute respiratory distress syndrome. J Thorac Dis. 2019;11(Suppl 3):S390-s393.
Sinha S, Patnaik R, Behera S. Steroids in acute respiratory distress syndrome: A panacea or still a puzzle? World J Crit Care Med. 2024;13(2):91225.
Sinha S, Patnaik R, Behera S. Steroids in acute respiratory distress syndrome: A panacea or still a puzzle? World Journal of Critical Care Medicine. 2024;13(2).
Bihari S, Bailey M, Bersten AD. Steroids in ARDS: to be or not to be. Springer; 2016. p. 931-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Telila Mesfin Tadesse, Olifan Getachew Wakjira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
